Clinical reportA novel homozygous KY variant causing a complex neurological disorder
Introduction
Homozygous loss of function variants in the gene kyphoscoliosis peptidase (KY) have primarily been implicated as a cause of rare neuromuscular phenotypes such as myofibrillar myopathy (MFM). The MFMs are a heterogeneous group of hereditary muscle diseases characterized by ectopic protein aggregates and a distinct pattern of myofibrillar disorganization (Fichna et al., 2018). Two reported variants, NM_178554.6:c.405C > A; p.(Tyr135Ter) and NM_178554.6:c.1071delG; p.(Thr358LeufsTer3) cause MFM7, characterized by pes cavus, muscular weakness and reduced reflexes in two Arab-Israeli brothers (Straussberg et al., 2016), and a Turkish girl (Hedberg-Oldfors et al., 2016), respectively. Another study reported a frameshift variant, NM_178554.6:c.51_52insTATCGACATGTGCTGTATCTATCGACAT; p.(Val18TyrfsTer56) causing hereditary spastic paraplegia (HSP) in twelve Arab-Bedouin individuals (Yogev et al., 2017). More recently, an Iranian patient with lower limb deformity and motor disorders was found to have a nonsense NM_178554.6:c.415C > T; p.(Arg139Ter) variant in KY (Ebrahimzadeh-Vesal et al., 2018).
The autosomal recessive ky mouse mutant exhibits a neuromuscular and skeletal phenotype with primary degenerative myopathy preceding chronic thoraco-lumbar kyphoscoliosis (Blanco et al., 2001). KY expression has been detected in several tissues including the brain (Fagerberg et al., 2014), and it encodes a protease which interacts with several muscle proteins such as filamin C (FLNC) and myosin-binding protein C (MYBPC1), suggesting that KY is an central part of the protein networks underlying the molecular mechanism of many limb-girdle muscular dystrophies (Beatham et al., 2004).
Section snippets
Clinical report
We performed genome-wide linkage analysis and whole exome sequencing to find the underlying cause of a complex neurological disorder in four of six affected individuals of a family (Fig. 1A, 2 family members were deceased and not available to study). This consanguineous family with multiple affected family members was selected for a potential gene discovery or novel gene-phenotype association. The study was conducted after approval by the institutional review board of School of Biological
Discussion
Our study has expanded both the phenotypic and genotypic spectrum due to KY variants. Interestingly, all KY variants described to date are predicted to either severely truncate the encoded protein or invoke nonsense mediated decay of the mRNA (Table 1). The KY variants may manifest with a spectrum of neurological phenotypes including myopathic, neurogenic or spastic paraplegia presentations.
The phenotype in the presented family included a mixture of upper and lower motor neuron signs. Given the
CRediT authorship contribution statement
Beenish Arif: Methodology, Investigation, Data curation, Writing - original draft, Writing - review & editing. Arisha Rasheed: Investigation, Data curation, Writing - review & editing. Kishore R. Kumar: Methodology, Investigation, Writing - review & editing. Amara Fatima: Methodology, Investigation, Data curation, Writing - review & editing. Ghazanfar Abbas: Investigation, Writing - review & editing. Elizabeth Wohler: Data curation, Writing - review & editing. Nara Sobriera: Data curation,
Declaration of competing interest
The authors declare that they have no conflict of interest.
Acknowledgements
We thank the family for participating in this research. We are grateful to Dr. Akbar Malik, and Huma Tariq for their help in the study. KRK receives a philanthropic grant from the Paul Ainsworth Family Foundation and a Working Group Co-Lead Award from the Michael J. Fox Foundation, Aligning Science Across Parkinson's (ASAP) initiative. KL is supported by German Research Foundation (DFG, grant LO1553/8-1). Whole exome sequencing was performed by Baylor-Hopkins Center for Mendelian Genomics. This
References (13)
- et al.
Identification of a novel nonsense mutation in kyphoscoliosis peptidase gene in an Iranian patient with myofibrillar myopathy
Genes Dis
(2018) - et al.
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics
Mol. Cell. Proteomics
(2014) - et al.
A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle
Neuromuscul. Disord.
(2016) - et al.
A global reference for human genetic variation
Nature
(2015) - et al.
Filamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibres
Hum. Mol. Genet.
(2004) - et al.
The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein
Hum. Mol. Genet.
(2001)
Cited by (3)
Genotypic and phenotypic spectrum of Myofibrillar Myopathy 7 as a result of Kyphoscoliosis Peptidase deficiency: The first description of a missense mutation in KY and literature review
2022, European Journal of Medical GeneticsCitation Excerpt :The high clinical overlap of symptoms and the resemblance of HSP to other clinical entities makes the molecular diagnosis of HSP essential (Hedera, 2021; Klebe et al., 2015). Although OMIM database only associates MFM-7 with mutations in KY, a handful of the previous studies reported that HSP is also caused by mutations in KY (Arif et al., 2020; Yogev et al., 2017). The main features of HSP are weakness and spasticity in both lower limbs.
Long-term course of a case with a novel homozygous kyphoscoliosis peptidase variant
2024, Journal of Human GeneticsA progressive KY myopathy could be caused by a missense pathogenic variant
2023, Clinical Genetics